Search for news
- International research at BESSY II continued even in the corona year 2021
2021 was not an easy year for international research: owing to lockdowns and travel bans, science was hit hard by the pandemic situation. Nevertheless, experiments continued at a high level at the BESSY II light source in Berlin Adlershof – thanks in part to new remote service offers. Here are the figures at a glance.
- Allianz der Wissenschaftsorganisationen: Aufruf zu mehr Sachlichkeit in KrisensituationenZur aktuellen Berichterstattung der BILD-Zeitung im Zusammenhang mit der Coronavirus-Pandemie erklärt die Allianz der Wissenschaftsorganisationen:
„Die BILD-Zeitung setzt mit dem Beitrag „Die Lockdown-Macher“ vom 4. Dezember 2021 ihre im vergangenen Jahr begonnene einseitige Berichterstattung gegen Wissenschaftlerinnen und Wissenschaftler fort, die ihre fachliche Expertise in den Dienst von Politik und Gesellschaft stellen, um der Coronavirus-Pandemie und ihren gerade in diesen Tagen dramatisch sichtbaren Folgen zu begegnen.
- HZB coordinates European collaboration to develop active agents against CoronaX-ray structure analysis at BESSY II enables the systematic testing of many thousands of molecules that could inhibit the reproduction and virulence of SARS-CoV2 viruses. Now, a team at HZB with partners from Austria and the Czech Republic has set up the NECESSITY project to investigate more than 8000 compounds in a high-throughput procedure and develop active agents against COVID-19.
- Synchrotrons accelerate corona researchInformation by the German Committee Research with Synchrotron Radiation (KFS).
Synchrotron light sources were originally built to study particles. Today, they are even used in the fight against COVID-19. The projects are as diverse as the fields of the synchrotron users, who come from universities, research institutions and companies like BioNTech.
- New substance library to accelerate the search for active compoundsIn order to accelerate the systematic development of drugs, the MX team at the Helmholtz-Zentrum Berlin (HZB) and the Drug Design Group at the University of Marburg have established a new substance library. It consists of 1103 organic molecules that could be used as building blocks for new drugs. The MX team has now validated this library in collaboration with the FragMAX group at MAX IV. The substance library of the HZB is available for research worldwide and also plays a role in the search for substances active against SARS-CoV-2.
- 04.05.2020 - #Corona: HZB resumes operation step by stepAfter a careful assessment of the situation, the management decided that operations at HZB would be resumed step by step from 4 May onwards. Strict security regulations apply. BESSY II will be available again for in-house research from 11 May. For Sars-CoV-2-relevant measurements a fast access to BESSY II has been established.
- Corona research: Consortium of Berlin research and industry seeks active ingredients
The Berlin biotech company Molox GmbH and a team at the Helmholtz-Zentrum Berlin (HZB) have initiated a consortium of regional research groups and BASF. Together, they want to identify a starting point for the development of a potential active substance against the new coronavirus. Targets of potential inhibitors will be SARS-CoV2 proteins that promote the spread or infectivity of the viruses. Scientists from Freie Universität Berlin are also involved in the research work.
- Corona research at BESSY II: Two days of measuring operation to find the right keyThe Berlin Synchrotron Source BESSY II of the Helmholtz-Zentrum Berlin (HZB) will resume operation for two days. Scientists intend to use the intense X-ray radiation from BESSY II to search for active substances against the corona virus SARS-CoV2. Almost two hundred samples from an important protein of the virus will be examined in the coming hours. The samples are saturated with different molecules that could be used as components of active substances. The analyses will show whether certain molecules can dock particularly well to the protein molecule and thus hinder the reproduction of the virus. These molecules are best candidates as components of a future drug.
- Coronavirus SARS-CoV2: BESSY II data accelerate drug developmentA coronavirus is keeping the world in suspense. SARS-CoV-2 is highly infectious and can cause severe pneumonia with respiratory distress (COVID-19). Scientists are doing research in order to prevent the viruses from multiplying. A team from the University of Lübeck and from Helmholtz Centre for Infection Research (HZI) has now found a promising approach. Using the high-intensity X-ray light from the Berlin synchrotron source BESSY II, they have decoded the three-dimensional architecture of the main protease of SARS-CoV-2. This protein is involved in the reproduction of the virus. Analysing its 3D architecture allows the systematic development of drugs which inhibit the reproduction of the virus.